EARLY SYMPTOMATIC THERAPY WITH ALGINATES AND ANTACIDS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

A randomized clinical trial enrolling 86 patients with gastroesophageal reflux disease (GERD) has demonstrated the higher efficacy of an alginate than that of an aluminum and magnesium antacid in relieving the symptoms of GERD and dyspepsia.

Full Text

Restricted Access

About the authors

V. Chukanov

Research Institute of Medical Problems of the North

Professor, MD

E. Onuchina

Irkutsk State Medical Academy of Postgraduate Education

Professor, MD

E. Kasparov

Research Institute of Medical Problems of the North

Professor, MD

S. Brikova

Clinical Hospital for War Veterans, Irkutsk

A. Vasyutin

Research Institute of Medical Problems of the North

Candidate of Medical Sciences

References

  1. El-Serag H., Sweet S., Winchester C. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review // Gut. - 2014; 63 (6): 871-80.
  2. Буторин Н.Н., Бичурина Т.Б., Цуканов В.В. и др. Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири // Тер. арх. - 2013; 1: 62-5.
  3. Everhart J., Ruhl C. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases // Gastroenterology. - 2009; 136 (2): 376-86.
  4. Kahrilas P., Keefer L., Pandolfino J. Patients with refractory reflux symptoms: What do they have and how should they be managed? // Neurogastroenterol. Motil. - 2015; 27 (9): 1195-201.
  5. Цуканов В.В., Онучина Е.В., Васютин А.В. и др. Тактика ведения больных гастроэзофагеальной рефлюксной болезнью с внепищеводными синдромами // Фарматека. - 2015; 6: 11-4.
  6. Цуканов В.В., Онучина Е.В., Каспаров Э.В. и др. Опыт длительной терапии пациентов с пищеводом Барретта // Фарматека. - 2015; 2: 62-5.
  7. Sharma P., Katzka D., Gupta N. et al. Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium // Gastroenterology. - 2015; 149 (6): 1599-606.
  8. Цуканов В.В., Онучина Е.В., Васютин А.В. и др. Клинические аспекты гастроэзофагеальной рефлюксной болезни у лиц пожилого возраста: результаты 5-летнего проспективного исследования // Тер. арх. - 2014; 2: 23-6.
  9. Lundell L., Dent J., Bennett J. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification // Gut. - 1999; 45 (2): 172-80.
  10. Vakil N., van Zanden S., Kahrilas P. et al. The Monreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus // Am. J. Gastroenterol. - 2006; 101 (8): 1900-20.
  11. Locke G., Talley N., Weaver A. et al. A new questionnaire for gastroesophageal reflux disease // Mayo Clin. Proc. - 1994; 69 (6): 539-47.
  12. Drossman D. The Functional Gastrointestinal Disorders and the Rome III Process // Gastroentrology. - 2006; 130 (5): 1377-90.
  13. Fletcher J., Wirz A., Young J. et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal // Gastroenterology. - 2001; 121 (4): 775-83.
  14. Beaumont H., Bennink R., de Jong J. et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD // Gut. - 2010; 59 (4): 441-51.
  15. Kahrilas P., McColl K., Fox M. et al. The acid pocket: a target for treatment in reflux disease? // Am. J. Gastroenterol. - 2013; 108 (7): 1058-64.
  16. Rohof W., Bennink R., Boeckxstaens G. Effect of PPIs on the size, position and acidity of the postprandial acid pocket // Gastroenterology. - 2012; 142: 92.
  17. Corvaglia L., Aceti A., Mariani E. et al. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants // Aliment. Pharmacol. Ther. - 2011; 33 (4): 466-70.
  18. Thomas E., Wade A., Crawford G. et al. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease // Aliment. Pharmacol. Ther. - 2014; 39 (6): 595-602.
  19. Sun J., Yang C., Zhao H. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China // Aliment. Pharmacol. Ther. - 2015; 42 (7): 845-54.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies